MeSH term
Frequency | Condition_Probility | Amino Acid Sequence | 12 | 0.0 |
Animals | 20 | 0.0 |
Base Sequence | 20 | 0.0 |
Cloning, Molecular | 10 | 0.0 |
Comparative Study | 6 | 0.0 |
Mice | 14 | 0.0 |
Molecular Sequence Data | 23 | 0.0 |
Promoter Regions (Genetics) | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 30 | 0.0 |
Sequence Alignment | 7 | 0.0 |
5' Flanking Region/genetics | 2 | 2.0 |
Binding Sites/genetics | 3 | 0.0 |
Chromosome Banding | 2 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
Humans | 32 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Rats | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Sequence Analysis, DNA | 5 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Transcription Factors/metabolism | 4 | 0.0 |
Xenopus | 2 | 0.0 |
Binding Sites | 7 | 0.0 |
Cell Line | 10 | 0.0 |
Cell Nucleus/metabolism | 4 | 0.0 |
DNA Mutational Analysis | 3 | 0.0 |
Enhancer Elements (Genetics) | 2 | 0.0 |
Mutagenesis, Site-Directed | 4 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Protein Binding | 6 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
Transcription, Genetic | 9 | 0.0 |
Transfection | 8 | 0.0 |
*Zinc Fingers | 3 | 1.0 |
Chloramphenicol O-Acetyltransferase/genetics/metabolism | 2 | 1.0 |
Female | 3 | 0.0 |
Promoter Regions (Genetics)/genetics | 6 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Tretinoin/pharmacology | 2 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Genes, myc/genetics | 3 | 3.0 |
Precipitin Tests | 2 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
RNA, Messenger/metabolism | 4 | 0.0 |
Recombinant Fusion Proteins/metabolism | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Transcription Factors/*metabolism | 5 | 0.0 |
Zinc Fingers | 9 | 1.0 |
3T3 Cells | 2 | 0.0 |
*Nuclear Proteins | 2 | 0.0 |
Transcription Factors/*genetics | 5 | 0.0 |
DNA/metabolism | 3 | 0.0 |
Hela Cells | 8 | 0.0 |
Models, Molecular | 3 | 0.0 |
Plasmids | 2 | 0.0 |
Transcription Factors/*chemistry | 2 | 4.0 |
Transcription Factor, Sp1/*physiology | 2 | 2.0 |
DNA-Binding Proteins/metabolism | 4 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Sequence Deletion | 4 | 0.0 |
Transcription Factor, Sp1/metabolism | 2 | 0.0 |
Gene Library | 2 | 0.0 |
*Gene Expression Regulation | 6 | 0.0 |
Genes, Reporter | 3 | 0.0 |
Organ Specificity | 2 | 0.0 |
*Promoter Regions (Genetics) | 9 | 0.0 |
Regulatory Sequences, Nucleic Acid | 2 | 0.0 |
Transcription Factors/*physiology | 2 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
Transcription Factors/chemistry/genetics/*metabolism | 2 | 1.0 |
Aspergillus Nuclease S1/metabolism | 2 | 11.0 |
Restriction Mapping | 3 | 0.0 |
Transcription, Genetic/genetics | 2 | 0.0 |
Structure-Activity Relationship | 3 | 0.0 |
Zinc Fingers/genetics | 3 | 1.0 |
TATA Box | 2 | 0.0 |
Transcription Factor, Sp1/*metabolism | 2 | 0.0 |
*Genes, myc | 4 | 1.0 |
Base Composition | 2 | 0.0 |
Zinc Fingers/genetics/*physiology | 2 | 10.0 |
Consensus Sequence | 3 | 0.0 |
Open Reading Frames | 2 | 0.0 |
Male | 4 | 0.0 |
Mutation | 2 | 0.0 |
Oligodeoxyribonucleotides | 2 | 0.0 |
*Terminator Regions (Genetics) | 2 | 14.0 |
